Evidence map›Paper›PMID 31930115›Full record

ArticleBioMed research international2019

Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression.

Yuka Murata, Takashi Yamashiro, Takaomi Kessoku, Israt Jahan, Haruki Usuda, Tetsuya Tanaka, Takayuki Okamoto, Atsushi Nakajima, Koichiro Wada

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. International journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Liraglutide suppresses obesity and promotes browning of white fat via miR-27bThe Journal of international medical research · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yuka MurataDepartment of Orthodontics and Dentofacial Orthopedics, Graduate School of Dentistry, Osaka University, Suita, 565-0871, Japan.
Takashi YamashiroDepartment of Orthodontics and Dentofacial Orthopedics, Graduate School of Dentistry, Osaka University, Suita, 565-0871, Japan.ORCID https://orcid.org/0000-0002-4419-9643
Takaomi KessokuDepartment of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Israt JahanDepartment of Pharmacology, Shimane University Faculty of Medicine, Izumo, 693-8501, Japan.
Haruki UsudaDepartment of Pharmacology, Shimane University Faculty of Medicine, Izumo, 693-8501, Japan.
Tetsuya TanakaDepartment of Pharmacology, Shimane University Faculty of Medicine, Izumo, 693-8501, Japan.
Takayuki OkamotoDepartment of Pharmacology, Shimane University Faculty of Medicine, Izumo, 693-8501, Japan.ORCID https://orcid.org/0000-0003-3536-7008
Atsushi NakajimaDepartment of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.ORCID https://orcid.org/0000-0003-3811-9704
Koichiro WadaDepartment of Pharmacology, Shimane University Faculty of Medicine, Izumo, 693-8501, Japan.ORCID https://orcid.org/0000-0001-9231-0556
Shimane University · JPThe University of Osaka · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by a spectrum of liver pathologies, from simple steatosis to steatohepatitis. Recent studies have increasingly noted the aberrant expression of microRNAs closely related to NAFLD pathologies. We have previously shown the presence of increased levels of microRNA-27b (miR-27b) in patients with NAFLD. In this study, we investigated the role of miR-27b in NAFLD by examining the impact of up-regulated miR-27b on the differentiation of preadipocytes into mature adipocytes. We found that miR-27b-3p remarkably enhances the adipocyte differentiation of 3T3-L1 cells associated with lipid accumulation and intracellular triglyceride contents. Furthermore, we have demonstrated not only that miR-27b-3p induces acyl-CoA thioesterase 2 (ACOT2) expression in 3T3-L1 cells, but also that the knockdown of ACOT2 suppresses lipid accumulation and adipocyte differentiation in both the presence and absence of miR-27b-3p treatment. Our data strongly suggest that the miR-27b-ACOT2 axis is an important pathway in adipocyte differentiation and may play a role in the pathogenesis of NAFLD.

Indexed as

3T3-L1 CellsAdipocytesAdipogenesisAnimalsCell DifferentiationCell LineMiceMicroRNAsNon-alcoholic Fatty Liver DiseasePalmitoyl-CoA HydrolaseRNA InterferenceTranscriptional ActivationUp-RegulationMicroRNAsMirn27 microRNA, mousemitochondrial acyl-CoA thioesterase I, mousePalmitoyl-CoA Hydrolase

Identifiers

PMID31930115
PMCPMC6942750
OpenAlexW2996448241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.